JAZZ Articles, Jazz Pharmaceuticals plc - From 01/31/24

An Australian, vertically integrated plant-based medicine company, Cannatrek, will collaborate with a Japanese University to empower research on m...

The negative sentiment observed in the stock market at the beginning of the year appears to persist, with index futures pointing to a lower opening...

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selecti...

Japan’s Parliament passed a bill Wednesday legalizing medical products derived from cannabis. The news comes some three weeks after the ...

Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants cond...

Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a m...

Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In...

Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confi...

Luxembourg: Medical Marijuana Shortage Due To Supplier Change The medical marijuana program in Luxembourg launched in Feb 2019 and has since ...

On Friday, cannabis stocks traded lower with the overall market. Marketfy analyst Michael Berger will be monitoring how the sector performs this we...